A case of Cunninghamella bertholettiae rhino-cerebral infection in a leukaemic patient and review of recent published studies

Mycopathologia

Volumn 165, Issue 6, 2008, Pages 407-410

  Righi, E ^a   Giacomazzi, C G ^a   Lindstrom, V ^a   Albarello, A ^a   Soro, O ^a   Miglino, M ^a   Perotti, M ^a   Varnier, O E ^a   Gobbi, M ^a   Viscoli, C ^a   Bassetti, M ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Cunninghamella bertholettiae; L amphotericin B; Leukaemia; Rhino cerebral

Indexed keywords

AMPHOTERICIN B;

ARTICLE; BONE MARROW TRANSPLANTATION; CASE REPORT; CUNNINGHAMELLA; DRUG EFFECT; HUMAN; IMMUNE DEFICIENCY; METABOLISM; MICROBIOLOGY; MUCORMYCOSIS; MYELOID LEUKEMIA; OPPORTUNISTIC INFECTION; PATHOGENICITY;

AMPHOTERICIN B; BONE MARROW TRANSPLANTATION; CUNNINGHAMELLA; HUMANS; IMMUNOCOMPROMISED HOST; LEUKEMIA, MYELOID; MUCORMYCOSIS; OPPORTUNISTIC INFECTIONS;

BACTERIA (MICROORGANISMS); CUNNINGHAMELLA; CUNNINGHAMELLA BERTHOLLETIAE; FUNGI;

EID: 44449103075     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-008-9098-z     Document Type: Article

References (21)

1. Maloisel F, Dufour P, Waller J, et al. Cunninghamella bertholletiae: an uncommon agent of opportunistic fungal infection: case report and review of the literature. Bone Marrow Transplant. 2000;25:1213-6.
2. Passos XS, Sales WS, Maciel PJ, Costa CR, Ferreira DM, do Silva MR. Nosocomial invasive infection caused by Cunninghamella bertolletiae: case report. Mycopathologia. 2006;161:33-5.
3. Sands JM, Macher AM, Ley TJ, Nienhuis AW. Disseminated infections caused by Cunninghamella bertolletiae in a patient with β-thalassemia. Ann Intern Med. 1995;102:59-63.
4. Zeilender S, Drenning S, Glauser FL, Bechard D. Fatal Cunninghamella bertolletiae infection in an immunocompetent patient. Chest. 1990;97:1482-3.
5. Hutter RVP. Phycomicetes infection (mucormicosis) in cancer patients: complication of therapy. Cancer. 1959;12:330-50.
6. Ribes JA, Vanover-Sams CL, Baker DJ. Zigomycetes in human disease. Clin Microbiol Rev. 2000;13:236-301.
7. Boyce JM, Lawson LA, Lockwood WR, Hughes JR. Cunninghamella bertholletiae wound infection of probable nosocomial origin. South Med J. 1981;74:1132-5.
8. Kontoyiannis DP, Vartivarian S, Anaissie EJ, Samonis G, Bodet GP, Rinaldi M. Infections due to Cunninghamella bertholletiae in patients with cancer: reports of three cases and review. Clin Infect Dis. 1994;18:925-8.
9. Pimentel JD, Dreyer G, Lum GD. Peritonitis due to Cunninghamella bertholletiae in a patient undergoing continuous ambulatory peritoneal dialysis. J Med Microbiol. 2006;55:115-8.
10. Sivakumar S, Mathews MS, George B. Cunninghamella pneumonia in postbone marrow transplant patient: first case report from India. Mycoses. 2005;48(5):360-2.
11. Ortín X, Escoda L, Llorente A, et al. Cunninghamella bertholletiae infection (mucormycosis) in a patient with acute T-cell lymphoblastic leukemia. Leuk Lymphoma. 2004;45(3):617-20.
12. Quinio D, Karam A, Leroy JP, et al. Zygomycosis caused by Cunninghamella bertholletiae in a kidney transplant recipient. Med Mycol. 2004;42(2):177-80.
13. Zhang R, Zhang JW, Szerlip HM. Endocarditis and hemorrhagic stroke caused by Cunninghamella bertholletiae infection after kidney transplantation. Am J Kidney Dis. 2002;40(4):842-6.
14. Singh J, Rimek D, Kappe R. In vitro susceptibility of 15 strains of zygomycetes to nine antifungal agents as determined by the NCCLS M38-A microdilution method. Mycoses. 2005;48(4):246-50.
15. Guinea J, Pelaez T, Alcala L, Bouza E. Comparison of sensititre yeastone with the NCCLS M38-A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus. Diagn Microbiol Infect Dis. 2006;56(1):53-5.
16. McNulty JS. Rhinocerebral mucormycosis: predisposing factors. Laryngoscope. 1982;92:1140-3.
17. Honda A Kamei K, Unno H, Hiroshima K, Kuriyama T, Miyaji M. A murine model of zygomycosis by Cunninghamella bertholletiae. Mycopathologia. 1998-1999;144(3):141-6.
18. Almyroudis NG, Sutton DA, Fothergill AW, Rinaldi MG, Kusne S. In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents. Antimicrob Agents Chemother. 2007;51 (7):2587-90.
19. Vazquez L, Mateos JJ, Sanz-Rodriguez C, Perez E, Caballero D, San Miguel JF. Successful treatment of rhinocerebral zygomycosis with a combination of caspofungin and liposomal amphotericin B. Haematologica. 2005;90(12):ECR39.
20. Mazade MA, Margolin JF, Rossmann SN, Edwards MS. Survival from pulmonary infection with Cunninghamella bertholletiae: case report and review of the literature. Pediatr Infect Dis J. 1998;17(9):835-9.
21. Ng TT, Campbell CK, Rothera M, Houghton JB, Hughes D, Denning DW. Successful treatment of sinusitis caused by Cunninghamella bertholletiae. Clin Infect Dis. 1994;19:313-6.